Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents

Completed · Not applicable

Conditions studied: Multi-antibiotic Resistance

In brief

Multidrug-resistant organisms (MDROs) are endemic in nursing homes (NHs) with prevalence rates surpassing those in hospitals. The aim of the study is to design and evaluate the effectiveness of a multi-component intervention to reduce new acquisition of MDROs in NH residents. The intervention will incorporate resident-level, environmental, and caregiver based strategies. Using a cluster-randomized study design, three NHs will be randomized to the intervention group and three to the control group. Control NHs will be allowed to continue standard infection prevention practices. Nursing homes will serve as the unit of allocation. Analyses will be performed both at the resident and the cluster level. The primary outcomes of the study are reduction in MDRO prevalence, and reduction in new MDRO acquisition .

Key facts

Study ID

NCT02909946

Run by

University of Michigan

People needed

246

Starts

2016-09-15

Expected to finish

2018-08-29

Last updated by the study team

2018-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years old
• Residing in a participating NH facility
• Provided informed consent for participation

You may not qualify if…

• Receiving end-of-life care
• Non-English language speaking

Where it is running

• University of Michigan and partner nursing homes — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.